PATH   LP7839-6

▸ Inflammatory cell infiltrate   LP433724-4

▸ Additional pathological findings   LP72054-7

▸ Adnexal involvement   LP420257-0

▸ Site of adnexal involvement   LP420258-8

▸ Anterior surgical resection   LP420277-8

▸ Associated nevus   LP344945-3

▸ Large B-cell lymphoma   LP411611-9

▸ Background endometrium findings   LP428202-8

▸ Biopsy   LP68311-7

▸ Bladder neck involvement   LP222111-9

▸ Body structure included in specimen   LP249953-3

▸ Body structure of origin   LP247928-7

▸ Breslow thickness   LP344943-8

▸ Calculus analysis   LP18632-7

▸ Carcinosarcoma component   LP428214-3

▸ Cerumen   LP263641-5

▸ Circumference   LP72247-7

▸ Coral fibers   LP420304-0

▸ Cyclic hormonal phase of endometrium   LP428209-3

▸ Cytokeratin 19 mRNA for cancer metastasis   LP438446-9

▸ DCIS intraductal extension   LP247940-2

▸ DCIS necrosis   LP247961-8

▸ DCIS.additional dimension 1   LP247936-0

▸ DCIS.additional dimension 2   LP247937-8

▸ DCIS.max dimension   LP247935-2

▸ Deepest extent of tumor invasion   LP222229-9

▸ Depth of invasion beyond muscularis propria   LP433636-0

▸ Desmoplastic melanoma   LP344944-6

▸ Dissection technique   LP212219-2

▸ Distant metastases confirmed by histology   LP222093-9

▸ Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved   LP247835-4

▸ Distance of carcinoma from closest surgical margin when all margins are uninvolved   LP247834-7

▸ Distance of carcinoma from anterior margin   LP247881-8

▸ Distance of carcinoma from inferior margin   LP247884-2

▸ Distance of carcinoma from lateral margin   LP247885-9

▸ Distance of carcinoma from medial margin   LP247886-7

▸ Distance of carcinoma from posterior margin   LP247882-6

▸ Distance of carcinoma from superior margin   LP247883-4

▸ Distance of tumor from cervical resection margins   LP428222-6

▸ Distance of tumor from circumferential resection margin   LP207882-4

▸ Distance of tumor from closest margin   LP72479-6

▸ Duodenum length   LP207896-4

▸ Esophagus length   LP207895-6

▸ Excised length   LP247831-3

▸ Extranodal extension of carcinoma   LP247959-2

▸ Extraprostatic extension extent   LP222106-9

▸ Extraprostatic extension site   LP222230-7

▸ Extramural vein invasion   LP222092-1

▸ Estrogen receptor   LP18567-5

▸ Foci   LP247932-9

▸ Glandular differentiation   LP247955-0

▸ Growth pattern of DCIS   LP247888-3

▸ HER2   LP28442-9

▸ Intramural vein invasion   LP222091-3

▸ Intratumoral lymphocytic response   LP247749-7

▸ Involvement of peritoneal biopsy specimen   LP428199-6

▸ Cells.Ki-67 nuclear   LP247969-1

▸ LCIS   LP247941-0

▸ Lymph node   LP72888-8

▸ Lymphovascular invasion   LP428220-0

▸ Margin involvement   LP95236-3

▸ Mesocolic excision plane   LP433635-2

▸ Sphincter excision plane   LP433634-5

▸ Microcystic elongated and fragmented (MELF) invasion pattern   LP428193-9

▸ Microscopic description   LP185969-5

▸ Microscopic observation   LP40224-5

▸ Path report.microscopic observation   LP64620-5

▸ Mitosis   LP419093-2

▸ Mucinous fraction   LP247842-0

▸ Myometrial invasion   LP428183-0

▸ Napsin A   LP429636-6

▸ Dominant nodule plane   LP222100-2

▸ Dominant nodule quadrant   LP222099-6

▸ Omental involvement   LP428198-8

▸ Other nodule plane   LP222101-0

▸ Other nodule quadrant   LP222108-5

▸ Other nodules greater than 10mm in diameter   LP222102-8

▸ Neuroendocrine tumor   LP428213-5

▸ Histology   LP72693-2

▸ Parametrial involvement   LP428201-0

▸ Path report.addendum   LP33133-7

▸ Pathology report additional specified observation   LP433026-4

▸ Path report.preliminary diagnosis   LP172645-6

▸ Pathology report reviewed   LP248064-0

▸ Pathologist review   LP18649-1

▸ Perineural invasion   LP73089-2

▸ Polyps   LP73128-8

▸ Primary mediastinal large B-cell lymphoma   LP411612-7

▸ Primary or recurrent or distant metastasis   LP428168-1

▸ Procedure used to obtain tumor specimen   LP247963-4

▸ Progesterone receptor   LP14902-8

▸ Promoter methylation testing method   LP247843-8

▸ Prostate cancer pathology   LP418969-4

▸ BRAF V600E mutant protein   LP248009-5

▸ Organ tumor is adherent to   LP247833-9

▸ Peritumoral lymphocytic response   LP247750-5

▸ Polyp in which invasive carcinoma arose   LP247840-4

▸ Position of rectal tumor in relation to anterior peritoneal reflection   LP222086-3

▸ Radial position in breast   LP247957-6

▸ Resection adequacy of non-malignant polyp   LP420278-6

▸ Residual tumor classification   LP222095-4

▸ Response to neoadjuvant therapy   LP222094-7

▸ Satellite nodules   LP222090-5

▸ Serosal classification   LP207879-0

▸ Seminal vesicles   LP222098-8

▸ Signet ring cells   LP247841-2

▸ Greater curvature of stomach   LP207809-7

▸ Lesser curvature of stomach   LP207810-5

▸ Stenosis degree   LP190754-4

▸ Stromal invasion   LP428196-2

▸ Surgical margin DCIS involvement   LP247960-0

▸ Surgical margin tumor involvement   LP247846-1

▸ Surgical margin tumor involvement.mesenteric   LP247839-6

▸ Thickness   LP64633-8

▸ Tissue block description and site   LP207887-3

▸ Tissue block identifier   LP417872-1

▸ Tissue blocks examined   LP247934-5

▸ Tissue blocks positive for DCIS   LP247938-6

▸ Tumor budding   LP247844-6

▸ Tumor buds   LP247845-3

▸ Tumor perforation   LP222064-0

▸ Tumor regression   LP73571-9

▸ Tumor regression at peripheral margin   LP344942-0

▸ Tumor type   LP207876-6

▸ Uterine serosa involvement   LP420259-6

▸ Vaginal involvement   LP420260-4

▸ Volume   LP73697-2

▸ Pathology dx ICD code   LP188440-4

▸ Pathology case identifier   LP269255-8

▸ Pathologist interpretation   LP19483-4

▸ Optimal tissue block   LP420261-2

▸ Specific antigens   LP57347-4

▸ Pathology study   LP431574-5

▸ Structured reporting protocol used   LP428211-9

▸ Pathology report intraoperative observation   LP231985-5

▸ Consultation note.synoptic   LP101574-4

▸ Report addendum.synoptic   LP101573-6

▸ Synoptic report   LP101572-8

▸ Vimentin   LP14700-6

▸ Pathology panels   LP116676-0